Drug costs: acquisition costs are critical but not the entire story of financial toxicity
BJU Int
.
2023 Aug;132(2):115-116.
doi: 10.1111/bju.16092.
Epub 2023 Jun 11.
Author
Deborah R Kaye
1
2
3
4
Affiliations
1
Department of Surgery, Duke University, Durham, NC, USA.
2
Duke-Margolis Center for Public Policy, Duke University, Durham, NC, USA.
3
Duke Clinical Research Institute, Durham, NC, USA.
4
Duke Cancer Institute, Durham, NC, USA.
PMID:
37302985
PMCID:
PMC11081428
DOI:
10.1111/bju.16092
No abstract available
Publication types
Editorial
Research Support, N.I.H., Extramural
Comment
MeSH terms
Cost of Illness
Costs and Cost Analysis
Financial Stress*
Health Care Costs
Health Expenditures
Humans
Neoplasms*
Grants and funding
K08 CA267062/CA/NCI NIH HHS/United States